Purdue, other drugmakers race to launch tamper-resistant drugs

04/28/2008 | Bloomberg11

Purdue Pharma LP next week will present a new formulation of its painkiller OxyContin to a panel of outside advisers to the FDA, as it competes with other companies to introduce tamper-resistant drugs that addicts cannot abuse. Alpharma, Pain Therapeutics and Elite Pharmaceuticals are working on alternative treatments to capture a share of a market that could be worth $1 billion.

View Full Article in:

Bloomberg11

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ
Health Plan CEO – Oregon
Trillium Community Health Plan
Eugene, OR
Director of Operations - GBS
Mayo Clinic
Rochester, MN